Administration, Intranasal
"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of medications through the nasal mucosa.
| Descriptor ID |
D000281
|
| MeSH Number(s) |
E02.319.267.120.655.500
|
| Concept/Terms |
Administration, Intranasal- Administration, Intranasal
- Intranasal Drug Administration
- Drug Administration, Intranasal
- Intranasal Administration
- Administrations, Intranasal
- Intranasal Administrations
- Administration, Intranasal Drug
- Administrations, Intranasal Drug
- Drug Administrations, Intranasal
- Intranasal Drug Administrations
- Administration, Nasal
- Administrations, Nasal
- Nasal Administration
- Nasal Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".
This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 5 | 5 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 9 | 9 |
| 2017 | 3 | 27 | 30 |
| 2018 | 2 | 34 | 36 |
| 2019 | 0 | 19 | 19 |
| 2020 | 1 | 11 | 12 |
| 2021 | 1 | 13 | 14 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.
-
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
-
Long-term olfactory dysfunction following coronavirus disease 2019 infection, routine neck dissection at salvage laryngectomy, parotid incidentalomas, and prescribing intranasal steroids in HIV infection. J Laryngol Otol. 2021 Sep; 135(9):753-754.
-
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation. Signal Transduct Target Ther. 2021 08 26; 6(1):318.
-
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection. mBio. 2021 08 31; 12(4):e0159821.
-
SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters. Nat Commun. 2021 08 17; 12(1):4985.
-
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study. Front Immunol. 2021; 12:709861.
-
Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model. PLoS Pathog. 2021 08; 17(8):e1009427.
-
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data. Pharmacol Res Perspect. 2021 08; 9(4):e00810.
-
Intravenous, Intratracheal, and Intranasal Inoculation of Swine with SARS-CoV-2. Viruses. 2021 07 30; 13(8).
-
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021 07 29; 13(8).